Navigation Links
Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
Date:4/27/2012

e eyes is often an early form of diabetic retinopathy that causes significant vision loss.  Almost all Type 1 diabetics and more than 60% of Type 2 diabetics will develop retinopathy. There is no effective daily drug treatment for diabetic retinopathy other than general measures, such as controlling blood sugar, hypertension, blood lipids, etc. Due to the global diabetes epidemic, diabetic retinopathy is recognized as a high, unmet medical need that would benefit from having oral therapeutic options available. The only treatments available for macular edema now are laser therapy, injection or implantation of drugs into or around the eyeball (not approved in the US or Canada). To our knowledge, Optina™ is the only proposed oral treatment for this condition.

About Optina™
Optina™ is an orally administered ultra low dose of danazol, for the treatment of diabetic macular edema (DME).  Ampio's Chief Scientific Officer discovered an unexpected activity in his investigation of the mechanism of action of danazol: very low doses reversed inflammation-induced increases in the permeability of blood vessels, thus reducing vascular leakage.  Dr. Bar-Or subsequently managed in-vitro studies that suggested this effect may reduce the vasogenic edema produced by various vascular leak syndromes, including diabetic macular edema (DME) which can impair vision and cause blindness. The specific Optina dosages used in the trial are proprietary and subject to multiple patent filings.

Danazol, a derivative of the synthetic steroid ethisterone, was approved by the FDA in the 1970s for endometriosis and, more recently, for other chronic indications, including hereditary angioedema, ITP and fibrocystic disease of the breast.

About Ampio
Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfun
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ampio Strengthens Patent Protection for Lead Drug Ampion™
2. Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule
3. Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results
4. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
5. Ampio Pharmaceuticals Schedules 2012 Outlook Webcast
6. Executive Changes at Ampio
7. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
8. Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
9. Ampio Responds to Recent Publications by Anonymous Short Sellers
10. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
11. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Nov. 21, 2014   Long Beach dentist , Dr. ... called the gold standard in tooth replacement because they offer ... long-lasting way to restore and preserve smiles and improve overall ... a missing tooth or as a part of a smile ... and feel of a smile. The loss of ...
(Date:11/22/2014)... ORLANDO, Fla. , Nov. 21, 2014 MEDITE ... 2014 reported nine months and the 3 rd quarter ... million. Operating income was $448,000 for the nine months ended ... September 2014. "Even though our 3 rd quarter is ... period which extends from July into September for many countries ...
(Date:11/22/2014)... , Nov. 21, 2014 Research and ... Recombinant Protein Drug Industry Report, 2014-2017" report to ... The Chinese recombinant protein drug market has ... rigidity, consumption ability and the like. During 2005-2013, sales ... grew at a CAGR of 19.1%, and it is ...
Breaking Medicine Technology:Long Beach Dentist, Dr. Rassouli, is Now Offering Dental Implants 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3
(Date:11/24/2014)... (PRWEB) November 24, 2014 Abington ... Ternopolska, MD has joined The Neurology Group and ... Multiple Sclerosis Center. , A graduate of Vinnica ... Neurology at Albert Einstein Medical Center in Philadelphia and ... Jaffe Multiple Sclerosis Center at Weill Cornell Medical College. ...
(Date:11/24/2014)... Recently, SweetDressy.com, a well-known dress supplier and leader ... 2014 Evening Dresses. All these fresh items are offered ... manager, the special offer is valid until Dec. 20, ... has been working well in the fashion industry for ... Their new dresses may be the best products for ...
(Date:11/24/2014)... The typical American diet includes foods that are ... a diet high in calories and carbohydrates only enables ... typically accumulate around the internal organs exposing people to ... the form of love handles, beer bellies and thunder ... rid themselves of the burden of embarrassing, unhealthy and ...
(Date:11/24/2014)... November 24, 2014 Dr. Michael Kettel ... Center, recently appeared on NBC to discuss egg freezing as ... has been trending in the news recently, with new company ... for women. , “[The companies] see it as ... on a career hot path.” Says Dr. Kettel. , Up ...
(Date:11/23/2014)... 24, 2014 For the coming special ... has launched a great promotion for many products, especially ... can get the best choice with amazing discounts, up ... Tidebuy.com. , It is easy to buy colored ... that, this selection is also famous for delicate craftsmanship, ...
Breaking Medicine News(10 mins):Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 3Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 4Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2
... Cell phone distractions account for more than 300,000 car crashes each ... to limit or prohibit the use of things like cell phones ... University finds a widening gap between the evidence on distracted driving ... new study, published this month in the American Journal of ...
... -- Patients with bipolar disorder may be eligible ... medications -- quetiapine (Seroquel), a widely prescribed second-generation ... stabilizer. NewYork-Presbyterian Hospital/Weill Cornell Medical Center is ... only site in the greater New York metropolitan ...
... By Steven Reinberg HealthDay Reporter , ... recommend antibiotics for asthma, almost 1 million children with ... in the United States, a new study finds. ... this suggests that we as pediatricians are prescribing them ...
... of tuberculosisas well as in the practices, programs and ... human immunodeficiency virus (HIV)the spread of multidrug-resistant (MDR) tuberculosis ... Research in the June issue of The Journal ... of 18F-FDG positron emission tomography (PET) scans can help ...
... immobilise radioactive forms of iodine using a microwave, has been ... Iodine radioisotopes are produced by fission of uranium fuel in ... it is highly mobile in the environment and selective uptake ... following long term exposure. Furthermore, iodine-129, which is a type ...
... , MONDAY, May 23 (HealthDay News) -- Are you the type ... theater? If so, here,s some good news: A new Norwegian study ... in better health than those who don,t. Both men and ... health and satisfaction with life than those who were less engaged. ...
Cached Medicine News:Health News:Temple-led study finds widening gap between distracted driving and legislation 2Health News:New study aims to improve long-term treatment for patients with bipolar disorder 2Health News:Too Many Kids Getting Antibiotics for Asthma 2Health News:Too Many Kids Getting Antibiotics for Asthma 3Health News:PET scans predict effectiveness of treatment for multidrug-resistant tuberculosis in HIV patients 2Health News:Expert discovers simple method of dealing with harmful radioactive iodine 2Health News:A Cultured Man Is a Healthier, Happier Man: Study 2Health News:A Cultured Man Is a Healthier, Happier Man: Study 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: